Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iveson

Showing results (481-490 of 573) with videos related to

Pageof 58
Sort By:
The New England Journal of Medicine|April 9, 2010
Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancerJuan Valle, Harpreet Wasan, Daniel H Palmer, et al.
Chemical Communications (Cambridge, England)|December 5, 2012
Gd3+ cFLFLFK conjugate for MRI: a targeted contrast agent for FPR1 in inflammationGraeme J Stasiuk, Helen Smith, Marzena Wylezinska-Arridge, et al.
BMJ Mental Health|January 17, 2025
Prevalence and patient characteristics associated with cardiovascular disease risk factor screening in UK primary care for people with severe mental illness: an electronic healthcare record studyNaomi Launders, Caroline Anne Jackson, Joseph F Hayes, et al.
JNCI Cancer Spectrum|June 23, 2021
Patients' Preferences for 3 Months vs 6 Months of Adjuvant Chemotherapy for Colon CancerPrunella Blinman, Andrew Martin, Michael Jefford, et al.
Bioorganic & Medicinal Chemistry Letters|August 21, 2012
Exploration of the structure-activity relationship of the diaryl anilide class of ligands for translocator protein--potential novel positron emitting tomography imaging agentsHarry Wadsworth, Paul A Jones, Wai-Fung Chau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2005
A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancerI Chau, A R Norman, D Cunningham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 23, 2010
A randomised comparative trial of infusional ECisF versus conventional FEC as adjuvant chemotherapy in early breast cancer: the TRAFIC trialB Sirohi, R A'Hern, G Coombes, et al.
BMC Public Health|February 20, 2022
Experience of clinical services shapes attitudes to mental health data sharing: findings from a UK-wide surveyE J Kirkham, S M Lawrie, C J Crompton, et al.
Lancet (London, England)|April 1, 2000
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trialJ Y Douillard, D Cunningham, A D Roth, et al.
European Journal of Cancer (Oxford, England : 1990)|December 3, 2014
A randomised, open-label phase II trial of afatinib versus cetuximab in patients with metastatic colorectal cancerTamas Hickish, Jim Cassidy, David Propper, et al.
Pageof 58

Showing results (481-490 of 573) with videos related to

Sort By:
Pageof 58
The New England Journal of Medicine|April 9, 2010
Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancerJuan Valle, Harpreet Wasan, Daniel H Palmer, et al.
Chemical Communications (Cambridge, England)|December 5, 2012
Gd3+ cFLFLFK conjugate for MRI: a targeted contrast agent for FPR1 in inflammationGraeme J Stasiuk, Helen Smith, Marzena Wylezinska-Arridge, et al.
BMJ Mental Health|January 17, 2025
Prevalence and patient characteristics associated with cardiovascular disease risk factor screening in UK primary care for people with severe mental illness: an electronic healthcare record studyNaomi Launders, Caroline Anne Jackson, Joseph F Hayes, et al.
JNCI Cancer Spectrum|June 23, 2021
Patients' Preferences for 3 Months vs 6 Months of Adjuvant Chemotherapy for Colon CancerPrunella Blinman, Andrew Martin, Michael Jefford, et al.
Bioorganic & Medicinal Chemistry Letters|August 21, 2012
Exploration of the structure-activity relationship of the diaryl anilide class of ligands for translocator protein--potential novel positron emitting tomography imaging agentsHarry Wadsworth, Paul A Jones, Wai-Fung Chau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2005
A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancerI Chau, A R Norman, D Cunningham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 23, 2010
A randomised comparative trial of infusional ECisF versus conventional FEC as adjuvant chemotherapy in early breast cancer: the TRAFIC trialB Sirohi, R A'Hern, G Coombes, et al.
BMC Public Health|February 20, 2022
Experience of clinical services shapes attitudes to mental health data sharing: findings from a UK-wide surveyE J Kirkham, S M Lawrie, C J Crompton, et al.
Lancet (London, England)|April 1, 2000
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trialJ Y Douillard, D Cunningham, A D Roth, et al.
European Journal of Cancer (Oxford, England : 1990)|December 3, 2014
A randomised, open-label phase II trial of afatinib versus cetuximab in patients with metastatic colorectal cancerTamas Hickish, Jim Cassidy, David Propper, et al.
Pageof 58